WHO Inter-Country Support Team office for East and Southern Africa, Harare, Zimbabwe.
Pan Afr Med J. 2021 Jun 24;39:147. doi: 10.11604/pamj.2021.39.147.28884. eCollection 2021.
the World health organisation (WHO) African Region reported the first confirmed COVID-19 case caused by the SARS-CoV-2 on 25 February 2020, and the first case for the East Southern Africa (ESA) sub-region was on 5 March 2020. Almost all countries in the ESA sub region implemented the WHO-recommended preventive measures variably after the notification of community transmission of the COVID-19 disease. This resulted in the disruption of the outpatient, immunization surveillance, and the related supply chain activities.
a comparative analysis study design of secondary acute flaccid paralysis (AFP) surveillance data received from the East and Southern Africa sub-region countries to evaluate the effect of the COVID-19 pandemic in the AFP field surveillance for the same time period of March to December 2019 and 2020.
we observed that 52.4% of second stool samples were received in the laboratory within 72 hours from March to December 2019, and only 48.1% in the same period of 2020. A 4.3% decline with a p-value of <0.0001 (95% CI, ranges from 2.326% to 6.269%). Similarly, we noted a 4.7% decline in the number of reported AFP cases in the ESA sub-region for March to December 2020 compared to the same period in 2019, a p-value of less than 0.001 (95% CI ranges from 2.785 to 6.614). For the percentage of stool adequacy, we observed a 3.37% decline for April in 2020 compared to April 2019 with a p-value of less than 0.001 (95% CI ranges from 2.059 to 4.690).
we observed a decline in the core AFP surveillance (non polio) NP-AFP rate, and percentage of stool adequacy in countries severely affected by the COVID-19 disease. These countries implemented stringent transmission prevention measures such as lock-down and international transportation restrictions.
世界卫生组织(WHO)非洲区域于 2020 年 2 月 25 日报告了首例由 SARS-CoV-2 引起的新冠肺炎确诊病例,东非和南非(ESA)次区域的首例病例于 2020 年 3 月 5 日报告。在通报新冠肺炎疾病社区传播后,ESA 次区域几乎所有国家都实施了世卫组织建议的不同程度的预防措施。这导致了门诊、免疫监测和相关供应链活动的中断。
对东非和南非次区域国家收到的急性弛缓性麻痹(AFP)监测数据进行二次分析,评估 2019 年 3 月至 12 月和 2020 年同期新冠肺炎疫情对 AFP 现场监测的影响。
我们观察到,2019 年 3 月至 12 月,实验室在 72 小时内收到 52.4%的第二份粪便样本,而 2020 年同期仅收到 48.1%。下降了 4.3%,p 值<0.0001(95%CI,范围为 2.326%至 6.269%)。同样,我们注意到,2020 年 3 月至 12 月,东非和南非次区域报告的 AFP 病例数与 2019 年同期相比下降了 4.7%,p 值<0.001(95%CI 范围为 2.785%至 6.614%)。关于粪便充足率,我们观察到 2020 年 4 月与 2019 年 4 月相比下降了 3.37%,p 值<0.001(95%CI 范围为 2.059%至 4.690%)。
我们观察到,在新冠肺炎疫情严重的国家,核心 AFP 监测(非脊灰)非脊灰 AFP 率和粪便充足率都有所下降。这些国家实施了严格的传播预防措施,如封锁和国际交通限制。